Insight: original analysis
This Week’s Diagnosis: The Administration remains active with the issuance of several new guidance documents, the drug pricing announcement and the President (finally) signing the bipartisan opioid legislation (HR 6).
© 2019. All Rights Reserved.
Design by: Knox Design Strategy